BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32050572)

  • 1. Persistent Urogenital Schistosomiasis and Its Associated Morbidity in Endemic Communities within Southern Ghana: Suspected Praziquantel Resistance or Reinfection?
    Tetteh-Quarcoo PB; Forson PO; Amponsah SK; Ahenkorah J; Opintan JA; Ocloo JEY; Okine EN; Aryee R; Afutu E; Anang AK; Ayeh-Kumi PF
    Med Sci (Basel); 2020 Feb; 8(1):. PubMed ID: 32050572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics in Morbidity Markers and Cytological Observations Made in Urine of
    Tetteh-Quarcoo PB; Ampong A; Dayie NTKD; Ahenkorah J; Udofia EA; Afutu E; Aryee R; Niriwa BP; Kotey FCN; Donkor ES; Ayeh-Kumi PF
    Med Sci (Basel); 2022 Feb; 10(1):. PubMed ID: 35225947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon.
    Dejon-Agobé JC; Edoa JR; Honkpehedji YJ; Zinsou JF; Adégbitè BR; Ngwese MM; Mangaboula A; Lell B; Woldearegai TG; Grobusch MP; Mordmüller B; Adegnika AA
    Parasit Vectors; 2019 Dec; 12(1):577. PubMed ID: 31823806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased ShTAL1 IgE responses post-Praziquantel treatment may be associated with a reduced risk to re-infection in a Ghanaian S. haematobium-endemic community.
    Asuming-Brempong EK; Ayi I; van der Puije W; Gyan BA; Larbi IA; Ashong Y; Frempong NA; Quartey JK; Otchere J; Jones FM; Wilson S; Dunne DW; Boakye DA
    PLoS Negl Trop Dis; 2022 Mar; 16(3):e0010115. PubMed ID: 35263327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urogenital schistosomiasis in three different water access in the Senegal river basin: prevalence and monitoring praziquantel efficacy and re-infection levels.
    Senghor B; Mathieu-Begné E; Rey O; Doucouré S; Sow D; Diop B; Sène M; Boissier J; Sokhna C
    BMC Infect Dis; 2022 Dec; 22(1):968. PubMed ID: 36581796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of praziquantel treatment regimens in pre-school and school aged children infected with schistosomiasis in sub-Saharan Africa: a systematic review.
    Kabuyaya M; Chimbari MJ; Mukaratirwa S
    Infect Dis Poverty; 2018 Jul; 7(1):73. PubMed ID: 29986763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
    Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
    Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Efficacy of Praziquantel in
    Houmsou RS; Wama BE; Agere H; Uniga JA; Amuta EU; Kela SL
    Sultan Qaboos Univ Med J; 2018 Aug; 18(3):e304-e310. PubMed ID: 30607270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of praziquantel on Schistosoma haematobium and re-infection rates among school-going children in the Ndumo area of uMkhanyakude district, KwaZulu-Natal, South Africa.
    Kabuyaya M; Chimbari MJ; Manyangadze T; Mukaratirwa S
    Infect Dis Poverty; 2017 Apr; 6(1):83. PubMed ID: 28385154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-aged children.
    Stete K; Krauth SJ; Coulibaly JT; Knopp S; Hattendorf J; Müller I; Lohourignon LK; Kern WV; N'goran EK; Utzinger J
    Parasit Vectors; 2012 Dec; 5():298. PubMed ID: 23259435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya.
    Kimani BW; Mbugua AK; Kihara JH; Ng'ang'a M; Njomo DW
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006852. PubMed ID: 30332403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of praziquantel on hematuria and proteinuria in urinary schistosomiasis.
    Mott KE; Dixon H; Osei-Tutu E; England EC; Davis A
    Am J Trop Med Hyg; 1985 Nov; 34(6):1119-26. PubMed ID: 3938926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Single Dose Praziquantel Treatment on Schistosoma haematobium Infection among School Children in an Endemic Nigerian Community.
    Adewale B; Mafe MA; Sulyman MA; Idowu ET; Ajayi MB; Akande DO; Mckerrow JH; Balogun EO
    Korean J Parasitol; 2018 Dec; 56(6):577-581. PubMed ID: 30630278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between child Schistosoma spp. infections and morbidity in an irrigated rice region in Mali: A localized study.
    Mutombo N; Landouré A; Man WY; Fenwick A; Dembélé R; Sacko M; Keita AD; Traoré MS; Webster JP; McLaws ML
    Acta Trop; 2019 Nov; 199():105115. PubMed ID: 31356787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three monthly doses of 60 mg/kg praziquantel for Schistosoma haematobium infection is a safe and effective treatment regimen.
    Darko SN; Hanson H; Twumasi-Ankrah S; Baffour-Awuah S; Adjei-Kusi P; Yar D; Owusu-Dabo E
    BMC Infect Dis; 2020 May; 20(1):323. PubMed ID: 32375658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity.
    Chisango TJ; Ndlovu B; Vengesai A; Nhidza AF; Sibanda EP; Zhou D; Mutapi F; Mduluza T
    BMC Infect Dis; 2019 Mar; 19(1):219. PubMed ID: 30832614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
    Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
    Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of praziquantel against urinary schistosomiasis and reinfection in Senegalese school children where there is a single well-defined transmission period.
    Senghor B; Diaw OT; Doucoure S; Sylla SN; Seye M; Talla I; Bâ CT; Diallo A; Sokhna C
    Parasit Vectors; 2015 Jul; 8():362. PubMed ID: 26156522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the benefits of five years of different approaches to treatment of urogenital schistosomiasis: A SCORE project in Northern Mozambique.
    Phillips AE; Gazzinelli-Guimaraes PH; Aurelio HO; Ferro J; Nala R; Clements M; King CH; Fenwick A; Fleming FM; Dhanani N
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006061. PubMed ID: 29220347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review.
    King CH; Olbrych SK; Soon M; Singer ME; Carter J; Colley DG
    PLoS Negl Trop Dis; 2011 Sep; 5(9):e1321. PubMed ID: 21949893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.